Andalusian Stem Cell Bank, Centro de Investigación Biomédica, Consejería de Salud-Universidad de Granada, Spain.
Cytotherapy. 2010;12(1):45-9. doi: 10.3109/14653240903377052.
Non-irradiated immunodeficient recipients provide the best physiologic setting for revealing hematopoietic stem cell (HSC) functions after xenotransplantion. An approach that efficiently permits the detection of human hematopoietic repopulating cells in non-irradiated recipients is therefore highly desired.
We compared side-by-side the ability to reconstitute hematopoiesis via intra-bone marrow transplantation (IBMT) in three commonly used mouse strains avoiding previous irradiation.
Non-irradiated NOD/SCID and NOD/SCID (beta2m-/- mouse strains prevent engraftment even after IBMT. In contrast, combining the robustness of the NOD/SCID IL-2Rgamma-/- recipient with the sensitivity of IBMT facilitates the detection, without previous host irradiation, of human SCID-repopulating cells 10 weeks after transplantation. The level of chimerism averaged 14% and multilineage engraftment (lymphoid dominant) was observed consistently in all mice. Analysis of injected and non-injected bones, spleen and peripheral blood demonstrated that engrafting cells were capable of in vivo migration and expansion.
Combining the robustness of the NOD/SCID IL-2Rgamma-/- mouse strain with the sensitivity of IBMT strongly facilitates long-term multilineage engraftment and migration for human CD34(+) cells without the need for previous irradiation.
未辐照的免疫缺陷受者为揭示异种移植后造血干细胞(HSC)的功能提供了最佳的生理环境。因此,非常需要一种能够在未辐照受者中有效检测人造血重编程细胞的方法。
我们比较了三种常用小鼠品系(避免先前照射)的骨髓内移植(IBMT)重建造血的能力。
未辐照的 NOD/SCID 和 NOD/SCID(β2m-/-)小鼠品系即使进行 IBMT 也会阻止植入。相比之下,将 NOD/SCID IL-2Rgamma-/-受者的稳健性与 IBMT 的敏感性相结合,无需先前的宿主照射,在移植后 10 周即可检测到人类 SCID 重编程细胞。嵌合率平均为 14%,所有小鼠均观察到多谱系植入(以淋巴样为主)。对注射和未注射骨、脾和外周血的分析表明,植入细胞能够进行体内迁移和扩增。
将 NOD/SCID IL-2Rgamma-/-小鼠品系的稳健性与 IBMT 的敏感性相结合,可在无需先前照射的情况下,强烈促进人 CD34(+)细胞的长期多谱系植入和迁移。